🇺🇸 Insulin Actrapid in United States

69 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Interaction — 17 reports (24.64%)
  2. Gastrointestinal Haemorrhage — 9 reports (13.04%)
  3. Hypoglycaemia — 7 reports (10.14%)
  4. Hyperglycaemia — 6 reports (8.7%)
  5. Blood Glucose Increased — 5 reports (7.25%)
  6. Bradycardia — 5 reports (7.25%)
  7. Pleural Effusion — 5 reports (7.25%)
  8. Pneumonia — 5 reports (7.25%)
  9. Renal Failure Acute — 5 reports (7.25%)
  10. Thrombocytopenia — 5 reports (7.25%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Insulin Actrapid approved in United States?

Insulin Actrapid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Insulin Actrapid in United States?

University of Nottingham is the originator. The local marketing authorisation holder may differ — check the official source linked above.